DEXABLISS Injection

DEXABLISS Injection is a parenteral formulation of Dexamethasone Sodium Phosphate I.P., a potent synthetic glucocorticoid used in a range of inflammatory and corticosteroid-responsive conditions. The injectable formulation is designed for intravenous or intramuscular administration in appropriate clinical settings where systemic corticosteroid therapy is required.

Dexamethasone provides pronounced anti-inflammatory and immunomodulatory activity and may be used in the management of severe allergic and inflammatory disorders. Its clinical applications include selected acute allergic conditions, corticosteroid-responsive inflammatory disorders and other situations where rapid parenteral corticosteroid therapy is considered appropriate.

DEXABLISS Injection is supplied as a 2 mL ampoule, with 10 ampoules per pack, and is intended for administration by qualified healthcare professionals. The injectable format provides flexibility for hospital and emergency-care settings where intravenous or intramuscular administration may be clinically indicated.

The product can be relevant to hospital departments, emergency-care facilities, intensive care units and institutional pharmaceutical procurement programs requiring injectable corticosteroid therapy. Its positioning within the anti-inflammatory and anti-allergic segments reflects the established therapeutic applications of dexamethasone sodium phosphate.

Dexamethasone sodium phosphate injection may also be used in selected conditions involving significant inflammatory responses, allergic manifestations and other corticosteroid-responsive disorders. Clinical use should always be based on the specific indication, patient condition and approved prescribing information.

DEXABLISS Injection should be administered only under appropriate medical supervision. Corticosteroid therapy requires consideration of the patient's underlying condition, duration of treatment and potential systemic effects. Appropriate dose selection and monitoring are important during parenteral administration.